István Láng

9.1k citations
118 papers · 4.4k · 1 hit paper · h-index 27

Impact in

  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Cancer-related Molecular Pathways
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

István Láng

111 papers receiving 4.3k citations

István Láng's Hit Papers

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study 2014 · 1.4k citations
1.4k0+4+8Years since publication4008001.2k

Peers

István Láng
Comparison fields: 5 of 150
  • Oncology 2.0k
  • Cancer Research 970
  • Pulmonary and Respiratory Medicine 2.0k
  • Genetics 246
  • Pharmacology 201
Replace Éric François with:
Éric François France
Tsunehiro Oyama Japan
Markus Borner Switzerland
Yasushi Totoki Japan
Helena Earl United Kingdom
Andries M. Bergman Netherlands
Evangelos Briasoulis Greece
Shigehira Saji Japan
Phillip D. Stricker Australia
Heung Tae Kim South Korea
István Láng relative to Éric François France Éric François's profile →
Citations per field
00.5×3.8×
Éric François · 1×
Citations per year

Countries citing papers authored by István Láng

Since Specialization
Citations

This map shows the geographic impact of István Láng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Láng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Láng more than expected).

Fields of papers citing papers by István Láng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by István Láng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Láng. The network helps show where István Láng may publish in the future.

Co-authors

The 25 scholars most cited alongside István Láng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with István Láng Line = papers co-authored together István Láng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Hit paper breakdown →
20141435
2 2008281
3 2011268
4 2007232
5 2005156
6 2016138
7 2016118
8 2016103
9 2014102
10 2017100
11 2011100
12 201890
13 201789
14
[Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
198983
15 201081
16
Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.
199156
17 201746
18 201644
19 201044
20
[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
199040

About István Láng

István Láng is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 118 papers that have together received 4.4k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (23 papers), HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (14 papers), Drug-Induced Hepatotoxicity and Protection (13 papers), Liver Disease Diagnosis and Treatment (9 papers), Pharmacological Effects of Natural Compounds (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (970 citations), Pulmonary and Respiratory Medicine (2.0k citations), Genetics (246 citations) and Pharmacology (201 citations). István Láng has collaborated with scholars based in Hungary, United States and Belgium. Frequent co-authors include John Crown, Richard S. Finn, Sophia Randolph, Katalin Boér, Dennis J. Slamon, Sindy T. Kim, Marcus Schmidt, Tamás Pintér, Xin Huang and Ravindranath Patel. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Immunology Letters and Cellular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact